Classic efforts have identified a “long-tail” distribution of cancer driver mutations, where some mutations (e.g., KRAS G12D [7]) are highly prevalent, and other mutations are extraordinarily rare [8, 9]. The gene discussed is KRAS; the disease is cancer.